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ABSTRACT
The study was conducted to measure the effectiveness of providing bottled water in reducing arsenic
exposure. Urine, tap-water and toenail samples were collected from non-smoking adults residing in Ajo
(n=40) and Tucson (n=33), Arizona, USA. The Ajo subjects were provided bottled water for 12 months
prior to re-sampling. The mean total arsenic (µg/L) in tap-water was 20.3±3.7 in Ajo and 4.0±2.3 in
Tucson. Baseline urinary total inorganic arsenic (µg/L) was significantly higher among the Ajo subjects
(n=40, 29.1±20.4) than among the Tucson subjects (n=32, 11.0±12.0, p<0.001), as was creatinine-adjusted
urinary total inorganic arsenic (µg/g) (35.5±25.2 vs 13.2±9.3, p<0.001). Baseline concentrations of
arsenic (µg/g) in toenails were also higher among the Ajo subjects (0.51±0.72) than among the Tucson
subjects (0.17±0.21) (p<0.001). After the intervention, the mean urinary total inorganic arsenic in
Ajo (n=36) dropped by 21%, from 29.4±21.1 to 23.2±23.2 (p=0.026). The creatinine-adjusted urinary
total inorganic arsenic and toenail arsenic levels did not differ significantly with the intervention.
Provision of arsenic-free bottled water resulted in a modest reduction in urinary total inorganic arsenic. 
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INTRODUCTION
Exposure of humans to inorganic arsenic is associated
with an increased risk of lung, bladder, skin and other can-
cers (1,2). Although inorganic arsenic is found through-
out the environment, drinking-water constitutes the most
significant source of exposure for most populations.
Moschandreas et al. have estimated the contribution of
drinking-water to the overall daily arsenic exposure to be
35%. Exposure of inorganic arsenic through ingestion
(food and water) also depends on certain demographic
characteristics, such as age, race/ethnicity, and poverty
level (3).  
On 22 January 2001, the U.S. Environmental Protection
Agency lowered the maximum contaminant level (MCL)
allowable for arsenic in drinking-water in the public
water systems, from 50 µg/L to 10 µg/L, beginning 23
January 2006 (4). Although this will reduce arsenic ex-
posure of drinking-water from the public water systems
that currently do not meet these standards, it will require
significant expenditure for modifications to these systems.
In addition, exposure at the new standard of the U.S.
Environmental Protection Agency may still confer health
risks. The costs involved in reduction of arsenic may not
be a reasonable option for small municipal water systems
or households using personal well-water. Hence, arsenic-
free bottled water may be a safe alternative in these
settings. 
In this study, we compared baseline urinary and toenail
arsenic in Ajo and Tucson, Arizona, USAand evaluated
the impact of providing arsenic-free bottled water, for
one year, on biomarkers of arsenic exposure in Ajo. The
primary hypothesis of the study was that provision of
bottled-water supplies would reduce arsenic exposure Reduction in arsenic exposure with bottled water 299
as measured by total inorganic arsenic species in urine
and concentrations of arsenic in toenails. 
MATERIALS AND METHODS
Study area and selection of households
Census blocks within census tracts were initially selected
at random. Based on a probability proportional to size
(PPS) sampling protocol (5), our goal was to recruit a
maximum of five households per census block. Our in-
clusion criteria required at least three years of continuous
residence in Ajo at the time of recruitment, age over 18
years, exclusive use of tap-water for drinking and food
preparation, and no current smoking. Given our restric-
tive inclusion criteria, we had difficulty in recruiting the
sufficient number of subjects using the PPS protocol in
Ajo. Subsequently, we resorted to a census of the entire
community. In Tucson, the five census tracts that most
closely resembled the Ajo population in age distribution
(median age= 52 years) and percentage of Hispanic resi-
dents (38%) in the 2000 census were selected. Two of
the five census tracts were randomly selected, and census
blocks and households in these blocks were randomized.
Again, we recruited up to five households per block.
The majority of households in both the communities that
did not meet the inclusion criteria reported extensive
use of bottled water. Recruitment of households took
place during June-August 2002 in Ajo and during July
2002_August 2003 in Tucson. Up to two eligible subjects
from each household were recruited. 
Sample collection
At the time of home-visit, participants completed a ques-
tionnaire adapted from the National Human Exposure
Assessment Survey regarding residential and occupa-
tional history, health status, smoking status, and source
of water. Water samples were collected using two sterile
50-cc polypropylene conical vials. Cold water
from kitchen faucet of participants was allowed to
run for one minute before collection began. The water
samples were stored at 4 ºC until analysis of arsenic.  
First-morning void urine samples were collected on
the day of appointment for sample collection from each
subject. Two sterile 120-cc screw-top containers were
provided for the collection of urine. These containers
had previously been tested to ensure that they did not
impart any measurable arsenic to stored liquid. Urine
samples were processed within two hours of collection
using the following protocol. The urine sample was re-
peatedly inverted and swirled to re-suspend the cells
into solution, and approximately 200 mLwas equally
aliquoted into four 50-mL vials and spun at 2,400 rpm 
for 12 minutes at room temperature. The supernatant
was then transferred to two 15-mL conical vials, tempo-
rarily stored at -20 °C, later transported to Tucson, and
stored at -70 °C prior to analysis for arsenic. On the
appointment day, subjects were provided toenail clippers
and small paper envelopes and were instructed to cut
their big toenails and other toenails of both feet after
taking their morning bath and to keep the toenail sam-
ples in the envelope for collection by the field team. 
Analysis of arsenic: urine and water
An HPLC-ICP-MS speciation method was modified
for the measurement of arsenic (6). The HPLC system
consisted of an Agilent 1100 HPLC (Agilent Technolo-
gies, Inc., Palo Alto, CA) with a reverse-phase C18
column (Prodigy 3µ ODS-3, 150x4.60 mm; Phenome-
nex, Torrance, CA). The mobile phase (pH 5.85) con-
tained 4.7 mM tetrabutylammonium hydroxide, 2 mM
malonic acid, and 4% (v/v) methanol at a flow rate of
1.2 mLper minute. Column temperature was maintained
at 50 °C. An Agilent 7500a ICP MS with a Babington
nebulizer was used as the detector. The operating para-
meters were as follows: Rf power_1,500 W; plasma gas
flow_15 L per minute; carrier flow_1.2 L per minute;
and arsenic was measured at m/z 75. For total arsenic,
an ASX500 autosampler (CETAC Technologies, Omaha,
NE) was used for introducing the samples into the Agi-
lent 7500a ICP-MS. The operating parameters were as
follows: Rf power_1,500 W; plasma gas flow_15 L per
minute; and carrier flow_1.2 L per minute. The acqui-
sition parameters were arsenic measured at m/z 75, ter-
bium (IS) measured at m/z 159, points per peak were 3,
dwell time for arsenic was 1.5 seconds, and the dwell time
for terbium was 1.5 seconds. Differential analysis of un-
stable MMA III and DMA III metabolites was not
possible. The sensitivity limits for arsenic species was
pre-determined to range from 0.04 to 0.08 µg/L. 
For this analysis, total inorganic arsenic was defined
as the sum of As3+, As5+, and the methylated metabolites
monomethylarsonic acid (MMA) and dimethylarsenic
acid (DMA). Urine or water arsenic species with levels
lower than the detectable limits were assigned values
of one-half the limit of detection for that particular arse-
nic species. The creatinine levels were estimated in urine
samples using the Jaffe reaction method in a microplate
format (Quidel Inc., San Diego, CA). Urinary arsenic
concentration was adjusted for creatinine by expressing
its level as a ratio with creatinine (µg/g creatinine). In
accordance with the recommendations of the World
Health Organization (WHO), urine samples with inade-
quate (<30 mg/dL; n=9) or excessive (>300 mg/dL;
n=1) concentrations of creatinine were not included in
analyses (7). 300 J Health Popul Nutr Sep 2006 Josyula AB et al.
Analysis of arsenic: toenails 
As part of a cooperative project involving the University
of Arizona and Dartmouth College, toenails were sent
to the Dartmouth College for analysis of arsenic. Each
toenail sample was washed with acetone, Triton X-100,
and water to remove external contaminants. Afterwards,
the complete sample was weighed into a Teflon vial, one
mL of concentrated HNO3 was added and capped, and
the sample was digested under pressure at 30 ºC in a
microwave oven. The resulting solution was added to
4 mLof water and stored at 5 ºC until analysis. For arse-
nic analysis, this solution was diluted an additional four
times with water and was analyzed using an Agilent
7500c ICP-MS instrument with an Octapole reaction
cell pressurized with helium gas to remove potential
interference from ArCl on m/z= 75, the mass of the arse-
nic ion. The detection limit was 0.005 µg/g.
Intervention: water delivery
Bottled water from Sparkletts® was tested to determine
levels of arsenic using methods similar to those described
above. Awater-cooler with a regular supply of bottled
water was provided to each participating household from
Ajo for one year. The participants were instructed to use
it for drinking, cooking, and preparation of all foods for
the entire year. At the end of the year, the study team
would return to collect another urine sample. Water was
delivered twice a month or according to the needs of
participants. The participants were telephoned over the
course of the year to ensure that they were using bottled
water for cooking and drinking and that enough was
being delivered for their needs. Samples of urine and
bottled water were collected at the end of one year using
the methods described above. 
Statistical analysis
Data were analyzed using SPSS 12.0 (Chicago, IL).
Population characteristics were compared using t-tests
and chi-square analysis. The Mann-Whitney U-test was
used for evaluating the differences at baseline in total
and speciated urinary arsenic measures between Ajo and
Tucson. Pre- and post-intervention-speciated urinary
arsenic and toenail arsenic levels among the Ajo parti-
cipants were compared using Wilcoxon signed rank test
for matched pairs. Spearman's rank correlation coeffi-
cient was used for evaluating correlations between levels
of arsenic in water, urine, and toenails. 
The Institutional Review Board at the University of
Arizona approved the study.
RESULTS
Forty subjects from 33 households in Ajo and 33 subjects
from 30 households in Tucson, who met eligibility re-
quirements, were enrolled in the study. Their demogra-
phic characteristics are presented in Table 1. There were
no significant differences between the Ajo and the Tucson
study subjects in terms of gender, age, age distribution,
race/ethnicity, past smoking, pre-existing illness, or the 
Table 1. Characteristics of participants in Ajo and
Tucson
Characteristics
Ajo (n=40)  Tucson (n=33)
No.      %      No.      %
Female 25 63 21 64
Age (mean±SD)              61.8±15.8      64.7±14.5
Age-group (years) 
<60 16 40 13 39
60-80 18 45 15 46
>80 6 15 5 15
Race/ethnicity
White/non-Hispanic 23 58 23 70
Hispanic 16 40 10 30
Other 1 2 0 0
Past smoker 18 45 12 40
Pre-existing illness
Ulcer 2 5 2 6
Asthma 14 35 16 48
Diabetes 8 20 5 15
Education
Less than high school 7 18 4 12
High school graduate 13 32 9 27
College and beyond 20 50 20 61
highest level of education attained. The participants were
predominantly female, aged over 60 years, with at least
a high school education. Approximately, one-third of
them from each town were Hispanic. During the inter-
vention, four subjects in Ajo dropped out of the study.
Baseline arsenic in water and urine
At baseline, no subjects used bottled water either for
cooking or for drinking. Table 2 shows that the mean
total arsenic in tap-water in Ajo was 20.3 µg/L (range
10.8-27.6 µg/L) and was significantly higher than that
in Tucson (mean 4.02 µg/L, range 0.8-9.5 µg/L, p<0.001).
Arsenate (As5+) was the major contributor to total inor-
ganic arsenic in water in both the towns, comprising
approximately 75% and 95% of the total in Tucson and
Ajo respectively. The baseline concentrations of total
urinary arsenic and total urinary inorganic arsenic were
significantly higher in Ajo than in Tucson (p<0.001 for
both). When the analysis was restricted to individuals
who did not consume arsenic-containing food items, Reduction in arsenic exposure with bottled water 301
including seafood or mushrooms, urinary arsenic con-
centration was still significantly lower in Tucson than
in Ajo. For urinary As3+, As5+, and MMA, 10%, 36%,
and 8% of the samples respectively were below the
limit of detection. The ratio of either MMAor DMAover
the sum of As3+ and As5+ and the ratio of DMA/MMA
did not differ significantly between the towns. Forty-
three baseline urine samples were determined to be valid
DMA/MMAratio. No significant changes in the relative
levels of MMA/(As3++As5+) or DMA/(As3++As5+) were
observed with the bottled-water intervention.  
When these comparisons were restricted to those 29
subjects who reported using bottled water for cooking,
drinking, and beverage preparation, the total inorganic
arsenic levels were significantly reduced with the inter-
Table 2. Characteristics of arsenic species in subjects from Tucson and Ajo at baseline
Arsenic species or ratio 
Ajo                           Tucson                     
p value Mean±SD                     Mean±SD
Tap-water (n) 33 29
Total arsenic (µg/L) 20.3±3.7 4.0±2.3 <0.001
Urine (n) 40 32
Total arsenic (µg/L) 28.3±18.6 14.0±13.5 <0.001
Total inorganic arsenic (µg/L) 29.1±20.4 11.0±12.0 <0.001
Creatinine (µg/dL)* 108.2±57.4 87.5±50.8                   0.254
Total inorganic arsenic/creatinine (µg/g)* 30.6±13.2 13.7±9.6 <0.001
As3+ (µg/L) 6.8±8.8 4.3±8.6 0.011
As5+ (µg/L) 2.0±2.6 0.2±0.5 < 0.001
MMA (µg/L) 2.9±3.7 1.0±1.1 < 0.001
DMA (µg/L) 17.5±12.5 5.5±4.4 < 0.001
MMA/(As3++As5+) 0.7±0.6 1.9±3.2 0.461
DMA/(As3++As5+) 5.1±5.9 10.8±14.1 0.225
DMA/MMA 13.1±29.0 14.4±23.1 0.511
Toenail (n) 38 33
Arsenic (µg/g)                                                       0.51±0.72                     0.17±0.21 0.001
*Valid values n=14 for Ajo and n=29 for Tucson; SD=Standard deviation
for adjustment of creatinine, based on the recommenda-
tions of WHO for concentrations of creatinine (Ajo, n=14;
Tucson, n=29). Twenty samples from Ajo were not avail-
able for analysis of creatinine. The population charac-
teristics of the subset of individuals with valid measure-
ments of creatinine were compared with the rest in each
group, but no significant differences were observed.
Baseline creatinine-adjusted total urinary inorganic
arsenic was significantly higher in Ajo than in Tucson
(p<0.001).  
Water intervention in Ajo and changes in speciated
urinary arsenic
Concentrations of arsenic in bottled water were all below
the limit of detection (~0.1 µg/L). Comparison of total
inorganic urinary arsenic concentrations at baseline and
follow-up revealed a 21% reduction associated with the
intervention (from 29.4 to 23.2 µg/L, p<0.026) (Table 3).
There was no significant difference in creatinine-adjusted
urinary total inorganic arsenic between the pre- and the
post-intervention (n=11). Drinking-water intervention
was associated with a significant reduction in DMAand
vention (31.0±22.9 vs 21.6±20.6 µg/L, p=0.013). How-
ever, creatinine-adjusted urinary inorganic arsenic was
not significantly reduced with the intervention (27.4±8.0
v. 27.3±24.4 µg/g, p=0.735). The relative proportions
of MMA/(As3++As5+) or DMA/(As3++As5+) did not vary
significantly with the intervention.  
Changes in toenail arsenic 
Toenails were collected, on average, within one week of
initial interview. At baseline, the toenail arsenic levels
were significantly higher in Ajo than in Tucson (Table 2).
When data from both the towns were combined, there
was a significant positive correlation between toenail
arsenic and total urinary inorganic arsenic (ρs=0.344,
p=0.004). There was a non-significant decline of approxi-
mately 47% between the pre- and the post-intervention
toenail arsenic level (p<0.061) (Table 3). For the 28
subjects who provided toenail samples and reported
exclusive use of bottled water for drinking and food pre-
paration during the intervention period, a significant re-
duction in concentrations of arsenic in toenails was
observed (0.53±0.75 µg/g vs 0.26±0.21 µg/g, p=0.032).302 J Health Popul Nutr Sep 2006 Josyula AB et al.
2.4 µg/kg body-weight of arsenic exposure (~37% of
which is inorganic), depending on the source and quan-
tity. Similarly, arsenic exposure from water could range
from as low as 0.1 to as high as 31 µg/kg of body-weight,
depending on locality of the water source. Quality of soil
and environmental air contributes a lesser extent to daily
arsenic exposure (8). Although we could not quantify all
these factors in our analysis, drinking-water intervention
alone may not sufficiently reduce daily arsenic exposure,
especially when the baseline daily exposure contribution
from water is not high.
Very little published information is available on the
effectiveness of provision of bottled water in reducing
arsenic exposure. Hopenhayn-Rich et al. studied the
effects of drinking-water intervention in individuals with
DISCUSSION
As expected, we found significantly increased total arse-
nic and total inorganic urinary arsenic, along with signifi-
cantly increased concentrations of arsenic in toenail in
Ajo compared to Tucson. This finding was consistent
with a higher exposure to arsenic in Ajo through tap-water.
Arsenic-free bottled-water intervention in Ajo signifi-
cantly reduced total inorganic arsenic in urine, although
the change was not observed with adjustment of creati-
nine, and the decline in toenail arsenic was only signifi-
cant when the analysis was restricted to those subjects
who reported exclusive use of bottled water. These
findings suggest that, over a one-year period, provision
of bottled water had limited effectiveness in reducing
arsenic exposure in this study community.
Table 3.  Arsenic species in Ajo before and after bottled-water intervention
Arsenic species or ratio                                        Pre-intervention            Post-intervention              p value 
Urine (n)                                                                        36                                 36
Total arsenic (µg/L) 28.3±18.9 22.4±21.4 0.035
Total inorganic arsenic (µg/L) 29.4±21.1 23.2±23.2 0.026
Creatinine (µg/dL)* 109.2±58.3 107.9±86.2 0.424
Total inorganic arsenic/creatinine (µg/g)* 27.8±10.1 31.8±23.7 0.79
As3+ (µg/L) 6.4±9.0 10.3±20.8 0.730
As5+ (µg/L) 2.1±2.7 1.7±1.9 0.943
MMA (µg/L) 3.0±3.8 2.0±1.8 0.091
DMA (µg/L) 17.9±12.7 9.1±8.1 <0.001
MMA/(As3++As5+) 0.7±0.6 1.2±3.5 0.814
DMA/(As3++As5+) 5.3±6.1 3.8±5.2 0.114
DMA/MMA 8.3±5.2 5.0±3.3 0.001
Toenail (n)                                                                     34                                 34
Arsenic (µg/g)                                                       0.49±0.68                      0.26±0.19 0.061
*Number of samples with available valid creatinine levels=11
As=Arsenic; DMA=Dimethylarsenic acid; MMA=Monomethylarsonic acid
Although the total urinary arsenic levels in Ajo were
reduced significantly with the bottled-water intervention,
the post-intervention urinary arsenic levels were still far
above those found in Tucson. This finding denotes that
some degree of arsenic exposure continued to occur
among the Ajo subjects despite the drinking-water inter-
vention. Although 29 of the 36 subjects reported exclu-
sive use of bottled water for cooking and drinking, the
intermittent use of tap-water for cooking and preparation
of beverages by the study subjects, and exposure to arse-
nic through food or other sources, may help explain the
limited effect observed with the intervention.  
Food and water are the major primary sources of non-
occupational daily arsenic exposure. According to the
toxicological profile of the U.S. Department of Health
and Human Services for arsenic, food contributes up to 
high arsenic exposure (>600 µg/L) (9). In the Hopenhayn-
Rich study, replacement drinking-water, which contained
arsenic at approximately 45 µg/L, was provided for two
months. The mean urinary total inorganic arsenic level
before and after drinking-water intervention was 636
µg/L and 166 µg/L respectively. Similar to our study,
the authors found a reduction in both DMA but also
found a reduction in MMA and inorganic arsenic. In
contrast to our study, the DMA/MMAratio increased
following the intervention.
Baseline measures of both MMAand DMAwere sig-
nificantly higher in individuals in Ajo than in Tucson,
but the ratio of either MMA/(As3++As5+) or DMA/
(As3++As5+) as respective indicators of primary and
secondary arsenic methylation activity in the liver, did
not differ significantly between the towns. However, theReduction in arsenic exposure with bottled water 303
DMA/MMAratio was significantly reduced with the in-
tervention. Approximately, 70-85% of the ingested arse-
nic is excreted through the kidney with DMAbeing the
principal metabolite. As reported in other studies, DMA
is the principal arsenic metabolite following low level
of arsenic exposure, trailed by MMAand inorganic forms
(9,10). Due to increased solubility and more rapid rate
of excretion, methylated forms (MMA and DMA) are
generally thought to be less acutely toxic than inorganic
forms. However, in more recent reports, Aposhian et al.
and Wildfang et al. suggested that arsenic methylation
may not be the universal detoxification mechanism for
arsenic as once thought (11,12). Other studies have
suggested that arsenic methylation may potentiate its
toxicity (13,14). Also, contrary to an earlier belief that
inorganic arsenite is the most toxic form of arsenic,
Petrick et al. described relative toxicity profiles in hu-
man liver cells in the following order:  MMA(III) >>>
As3+ >> As5+ >> MMA (V)=DMA (V) (15). 
Our study had several limitations. Estimates of total
arsenic exposure through diet, water, dust, and air were
not available. Although increased exposure to environ-
mental arsenic near copper-smelting towns has been well-
documented (16), we were unable to assess the contri-
bution of exposures at work or away from home. Another
documented source of exposure to arsenic is through
food, especially fish (3), and consumption of foods grown
in arsenic-contaminated soils (17). However, measure-
ment of inorganic arsenic concentration rather than the
total arsenic concentrations should reduce confounding
effects of seafood ingestion, and in a previous study in
two Arizona mining towns, concentration of arsenic in
house-dust was not associated with urinary arsenic con-
centrations in adults (18). Because urine creatinine levels
were only available for 11 individuals from Ajo at base-
line, our statistical power to detect pre- and post-inter-
vention differences in creatinine-adjusted arsenic levels
was limited. 
In conclusion, the arsenic-free drinking-water inter-
vention resulted in only modest reductions in urinary
arsenic concentrations. The total inorganic urinary arse-
nic level was reduced by 21%, although analysis of crea-
tinine-adjusted urinary and toenail arsenic failed to cor-
roborate significant reduction in arsenic exposure. This
implies that there was probably greater use of tap-water
for food and beverage preparations than realized or re-
ported and/or that other non-water sources of arsenic
were present. Evaluations of similar populations before
and after providing water-treatment systems, as contrasted
with bottled water, would provide a useful comparison. 
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